Avenue Therapeutics
(OTC) ATXI
Avenue Therapeutics Financials at a Glance
Market Cap
$1.15M
Revenue (TTM)
$1.40M
Net Income (TTM)
$2.91M
EPS (TTM)
$-0.96
P/E Ratio
-0.37
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$0.45
Volume
4,514
Open
$0.35
Price
$0.45
Volume
4,514
Open
$0.35
Previous Close
$0.45
Daily Range
$0.35 - $0.46
52-Week Range
$0.15 - $0.97
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$0.45
Volume
4,514
Open
$0.35
Previous Close
$0.45
Daily Range
$0.35 - $0.46
52-Week Range
$0.15 - $0.97
ATXI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Avenue Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
1
CEO
Alexandra MacLean, MD, MBA
Website
www.avenuetx.comHeadquarters
New York City, NY 10036, US
ATXI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-126%
Return on Capital
-2%
Return on Assets
-99%
Earnings Yield
-2.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.15M
Shares Outstanding
3.29M
Volume
4.51K
Short Interest
0.00%
Avg. Volume
6.08K
Financials (TTM)
Gross Profit
$1.40M
Operating Income
$3.29M
EBITDA
$3.29M
Operating Cash Flow
$1.83M
Capital Expenditure
$0.00
Free Cash Flow
$1.83M
Cash & ST Invst.
$2.85M
Total Debt
$0.00
Avenue Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.40M
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.15M
N/A
Market Cap/Employee
$576.55K
N/A
Employees
2
N/A
Net Income
$709.00K
+54.1%
EBITDA
$955.00K
+38.7%
Quarterly Fundamentals
Net Cash
$2.85M
+10.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-99.25%
N/A
Return on Invested Capital
-1.79%
N/A
Free Cash Flow
$854.00K
-11.8%
Operating Cash Flow
$854.00K
-11.8%